Cystatin C versus creatinine for kidney function-based risk

Comment

Michael G Shlipak et al. N Engl J Med. 2013.

. 2013 Dec 19;369(25):2459.

doi: 10.1056/NEJMc1312801.

No abstract available

Comment on

Cystatin C versus creatinine in determining risk based on kidney function.
Shlipak MG, Matsushita K, Ärnlöv J, Inker LA, Katz R, Polkinghorne KR, Rothenbacher D, Sarnak MJ, Astor BC, Coresh J, Levey AS, Gansevoort RT; CKD Prognosis Consortium. Shlipak MG, et al. N Engl J Med. 2013 Sep 5;369(10):932-43. doi: 10.1056/NEJMoa1214234. N Engl J Med. 2013. PMID: 24004120 Free PMC article.
Cystatin C versus creatinine for kidney function-based risk.
Tavares AR Jr. Tavares AR Jr. N Engl J Med. 2013 Dec 19;369(25):2457-8. doi: 10.1056/NEJMc1312801. N Engl J Med. 2013. PMID: 24350960 No abstract available.
Cystatin C versus creatinine for kidney function-based risk.
Cherney D, Maahs DM. Cherney D, et al. N Engl J Med. 2013 Dec 19;369(25):2458. doi: 10.1056/NEJMc1312801. N Engl J Med. 2013. PMID: 24350961 No abstract available.
Cystatin C versus creatinine for kidney function-based risk.
Vandecasteele SJ, De Vriese AS. Vandecasteele SJ, et al. N Engl J Med. 2013 Dec 19;369(25):2458-9. doi: 10.1056/NEJMc1312801. N Engl J Med. 2013. PMID: 24350962 No abstract available.